Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

434 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

NCT04644770

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

TheraSphere With Durvalumab and Tremelimumab for HCC

NCT05063565

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of Arizona- Banner Health Tucson, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

NCT04704934

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations
  • Instituto Medico Especializado Alexander Fleming Colegiales, Buenos Aires F.D., Argentina
  • IONC Instituto Oncologico de Cordoba - Fundacion Richardet Longo Nueva Cordoba, Córdoba Province, Argentina
  • Exelsus San Miguel de Tucumán, Tucumán Province, Argentina
  • Fundacion Cenit Buenos Aires, Argentina
View all 156 locations
View Trial Details
Active, Not Recruiting

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

NCT06564844

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Glendale, California, United States
  • Research Site Los Angeles, California, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

THIO Sequenced With Cemiplimab in Advanced NSCLC

NCT05208944

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Summit Health Florham Park, New Jersey, United States
  • Sunshine Coast Haematology and Oncology Clinic Buderim, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View all 35 locations
View Trial Details
Active, Not Recruiting

A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

NCT03504397

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • University of Arizona Phoenix, Arizona, United States
  • The University of Arizona Medical Center Tucson, Arizona, United States
  • CBCC Global Research, Inc. at Comprehensive Blood and Cancer Bakersfield, California, United States
  • City of Hope Nat'l Medical Center Duarte, California, United States
View all 220 locations
View Trial Details

Related conditions